Press Releases

Sep 18, 2025 6:00am EDT

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland

Sep 10, 2025 6:00am EDT

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation

Aug 20, 2025 9:25am EDT

Noble Capital Markets Initiates Equity Research Coverage on Greenwich LifeSciences

Aug 19, 2025 6:00am EDT

Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team

Aug 13, 2025 6:00am EDT

Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania

Aug 11, 2025 6:00am EDT

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

Apr 03, 2025 8:00am EDT

Greenwich LifeSciences Provides Global Update on FLAMINGO-01

Apr 02, 2025 6:00am EDT

Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial

Mar 27, 2025 6:00am EDT

Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026

Mar 17, 2025 6:45am EDT

Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01